Brief: TELA Bio Q2 Revenue USD 16.091 Million Vs. IBES Estimate USD 18.5 Million
12/08/2024 21:05
Aug 12 (Reuters) - TELA Bio Q2 basic EPS USD -0.51. * Q2 net income USD -12.6 million * Q2 income from operations USD -11.57 million * Q2 gross profit USD 11.073 million * Q2 operating expenses USD 22.643 million * outlook FY revenue USD 74.5-76.5 million
Recent news on TELA Bio
See all newsBrief: Tela Bio - Receives FDA 510(K) Clearance For Liora Monofilament Scaffold For Soft Tissue Reinforcement
Tela Bio Inc Reports Results For The Quarter Ended June 30: Earnings Summary
TELA Bio Q2 revenue falls on lower OviTex PRS volumes, withdraws outlook
Brief: TELA Bio Q2 Revenue USD 19.291 Million Vs. IBES Estimate USD 20 Million
Tela Bio Inc Expected To Post A Loss Of 18 Cents A Share: Earnings Preview